Abstract
New therapeutic strategies are direly needed in the fight against cancer. Histotripsy is the first completely noninvasive, nonthermal, and nonionizing tumor ablation method, capable of producing consistent and rapid ablations even near critical structures. While small animal models have been critical for providing mechanistic insight, they possess significant limitations in terms of scale and anatomical relevance. To address this "translational gap," a diverse range of large animal models and spontaneous tumor studies in veterinary patients have emerged. These models provide realistic avenues for developing and testing histotripsy devices designed for future human use. This review compares histotripsy ablation across a broad spectrum of preclinical models and spontaneous tumors in veterinary patients.
Introduction: The Problem of Scale and Anatomy
While many cancer therapies show promise in murine studies, they often fail in human trials. For focal ablation technologies like histotripsy, small animal models present three primary hurdles:
- Scale: A mouse tumor is often smaller than the ultrasound focal zone itself, failing to simulate the challenges of targeting deep-seated human organs.
- Anatomy: Mice lack the complex "acoustic windows"—such as rib cages or gas-filled bowels—that complicate ultrasound delivery in larger bodies.
- Biological Complexity: Lab-grown tumors in inbred mice lack the genetic heterogeneity and complex immune environments of naturally occurring human cancers.
Methodology: Scaling the Technology
The transition from benchtop to bedside requires distinct hardware configurations. Small animal systems typically utilize custom 1-MHz transducers designed for high precision at shallow depths (<1.5 cm). In contrast, clinical prototypes for large animals and humans use 500-kHz, multi-element arrays mounted on robotic micropositioners, designed for depths of approximately 7 cm and integrated with clinical-grade real-time ultrasound imaging.
Both systems rely on acoustic cavitation, where microsecond-long, high-pressure ultrasound pulses generate "bubble clouds." These clouds mechanically homogenize target tissue into acellular debris without generating heat, allowing for tissue-selective ablation that can spare critical structures like major blood vessels.
Key Results in Large Animal and Veterinary Models
The research highlights several breakthroughs in moving beyond rodent models:
- Genetically Engineered Porcine Models: The development of immunocompromised pigs (RAG2/IL2RG deficient) allows for the hosting of human cancer cell lines, creating "human-sized" tumors within a body that mimics human organ structures.
- Porcine Pancreas Ablation: Researchers reported the first instance of histotripsy used to target the pancreas in a large animal, identifying stomach gas as a primary hurdle for the acoustic window.
- Comparative Oncology in Canines: Client-owned pet dogs with spontaneous Soft Tissue Sarcoma (STS) and Osteosarcoma (OS) serve as "sentinel" models. Because these dogs share human environments and have intact immune systems, they provide a rigorous test for histotripsy’s ability to stimulate systemic anti-tumor immune responses.
In canine clinical pilots, histotripsy produced well-defined ablation zones visible on CT as regions of decreased contrast uptake. Histology confirmed extensive cell necrosis and hemorrhage within the targeted volumes, matching planned 3-cm treatment zones.
Limitations and Future Directions
Despite these successes, challenges remain regarding acoustic windows. Gas in the GI tract and the high density of bone can block or distort ultrasound waves. Future work is focused on developing "acoustic nutrients" (specialized diets) to clear bowel gas and improving transcostal delivery methods. Additionally, while CT and MRI can identify ablation zones, improved multi-modal imaging is needed to better distinguish between liquefied tissue and surrounding edema. The next major frontier is quantifying the systemic immune response triggered by the release of tumor antigens during mechanical homogenization.
Summary updated